重症监护病房院内心脏骤停的患病率与结局:系统评价与荟萃分析
该系统评价与荟萃分析纳入35项观察性研究(36个队列),评估成人ICU内心脏骤停(ICU-CA)的患病率与结局。汇总ICU-CA比例为3.23%(95%CI 2.08–4.98,中等确定性),COVID-19患者为10.6%,显著高于非COVID-19队列的2.3%。汇总ICU死亡率为74.0%(中等确定性),院内死亡率为82.0%(高确定性)。Meta回归显示可除颤心律比例与ICU死亡率呈负相关,但与院内死亡率无关。
要点
- 成人ICU-CA汇总患病率为3.23%(95%CI 2.08–4.98,中等确定性证据)。
- COVID-19患者ICU-CA患病率10.6%(95%CI 5.4–19.7),显著高于非COVID-19队列的2.3%(95%CI 1.5–3.5),p<0.001。
- 汇总ICU死亡率为74.0%(95%CI 63.7–82.1,中等确定性),院内死亡率为82.0%(95%CI 75.9–86.9,高确定性)。
- Meta回归显示可除颤心律比例与ICU死亡率呈负相关,但与院内死亡率无关。
- 作者认为未来研究应聚焦围骤停期特征,以指导ICU-CA患者的预后判断与管理。
适用人群与场景
- 成人ICU内发生心脏骤停的患者(系统评价纳入35项观察性研究、36个队列)。
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入35项观察性研究(36个队列),检索MEDLINE、Embase和Scopus自建库至2025年11月26日。
- 主要终点:ICU-CA汇总患病率为3.23%(95%CI 2.08–4.98,中等确定性)。
- 亚组:COVID-19患者ICU-CA患病率10.6%(95%CI 5.4–19.7)vs 非COVID-19队列2.3%(95%CI 1.5–3.5),COVID-19组显著更高(p<0.001)。
- 次要终点:汇总ICU死亡率74.0%(95%CI 63.7–82.1,中等确定性),院内死亡率82.0%(95%CI 75.9–86.9,高确定性)。
- Meta回归:可除颤心律比例与ICU死亡率呈负相关,但与院内死亡率无关。
- 亚组分析基于地理区域(洲)、研究来源(登记 vs 非登记)和COVID-19状态(感染 vs 未感染)。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入35项观察性研究。
- 偏倚风险评估采用Joanna Briggs Institute清单,证据确定性采用GRADE方法评估。
- 主要终点(ICU-CA患病率)和ICU死亡率为中等确定性证据,院内死亡率为高确定性证据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未来研究应聚焦围骤停期特征,以指导ICU-CA患者的预后判断与管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac arrest in the intensive care unit (ICU-CA) is distinct from other in-hospital cardiac arrests, involving critically ill patients in monitored settings. Its prevalence and outcomes remain unclear. This systematic review and meta-analysis aimed to fill this evidence gap and identify areas for future research to improve outcomes in this patient population. METHODS: We searched MEDLINE, Embase and Scopus databases from inception until 26 November 2025 for studies reporting on ICU-CA in adults. We performed random effects meta-analyses with the generalised linear mixed model. We used the Joanna Briggs Institute Checklist to assess risk of bias and the GRADE approach to assess the certainty of evidence. The primary outcome was the prevalence of patients with ICU-CA; secondary outcomes included ICU and in-hospital mortality. We performed subgroup analyses based on geographical region (continent), study source (registry vs. non-registry), and COVID-19 status (infected vs. non-infected). RESULTS: We included 35 observational studies including 36 cohorts in the meta-analysis. The pooled proportion of ICU-CA was 3.23% (95% CI: 2.08–4.98, moderate certainty). The proportion of ICU-CA was significantly higher (p < 0.001) in patients with COVID-19 (10.6%, 95%-CI: 5.4–19.7) compared with non-COVID-19 cohorts (2.3%, 95%-CI: 1.5–3.5). Pooled ICU mortality was 74.0% (95%-CI: 63.7–82.1, moderate certainty) and in-hospital mortality was 82.0% (95%-CI: 75.9–86.9, high certainty). Meta-regression found that proportion of shockable rhythm was inversely associated with ICU mortality, but not in-hospital mortality. CONCLUSION: Cardiac arrest in the ICU was associated with poor survival, with a higher prevalence in patients with COVID-19. Future studies should focus on peri-arrest characteristics to guide prognostication and management of individuals who experience ICU-CA.
参考来源
- Lim O, Ling RR, Mak V, et al. Prevalence and outcomes of in-hospital cardiac arrest in the intensive care unit: a systematic review and meta-analysis. Crit Care. 2026. PMID: 41761217. doi:10.1186/s13054-026-05880-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。